Loading...
Combination therapy for metastatic renal cell carcinoma
Current therapy for metastatic clear cell renal cell carcinoma (RCC) consists of the serial administration of single agents. Combinations of VEGF and mTOR inhibitors have been disappointing in previous randomized trials. However, the combination of lenvatinib, a multitargeted agent that inhibits VEG...
Na minha lista:
| Udgivet i: | Ann Transl Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4791344/ https://ncbi.nlm.nih.gov/pubmed/27047959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.01.31 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|